{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:35:33Z","timestamp":1695004533852},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cjca.2017.01.007","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T06:47:23Z","timestamp":1484894843000},"page":"611-618","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Precision Medicine for Hypertension Management in Chronic Kidney Disease: Relevance of SPRINT for Therapeutic Targets in Nondiabetic Renal Disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Marcel","family":"Ruzicka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin D.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapnil","family":"Hiremath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2017.01.007_bib1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jama.1967.03130240070013","article-title":"Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg","volume":"202","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2017.01.007_bib2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib3","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A\u00a0randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib4","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1161\/01.CIR.61.6.1179","article-title":"Perspectives on systolic hypertension. The Framingham study","volume":"61","author":"Kannel","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.01.007_bib7","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib8","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2017.01.007_bib11","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2017.01.007_bib12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5694\/mja16.00526","article-title":"Guideline for the diagnosis and management of hypertension in adults - 2016","volume":"205","author":"Gabb","year":"2016","journal-title":"Med J Aust"},{"key":"10.1016\/j.cjca.2017.01.007_bib13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cjca.2016.02.066","article-title":"Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"32","author":"Leung","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.01.007_bib14","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2017.01.007_bib15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"key":"10.1016\/j.cjca.2017.01.007_bib16","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2017.01.007_bib18","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib19","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2013reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0140-6736(05)70156-2","article-title":"Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2017.01.007_bib21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1161\/CIRCULATIONAHA.110.970160","article-title":"Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography","volume":"123","author":"James","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.01.007_bib22","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1681\/ASN.2015060642","article-title":"Evaluation of short-term changes in serum creatinine level as a meaningful end point in randomized clinical trials","volume":"27","author":"Coca","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cjca.2017.01.007_bib23","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1093\/ndt\/gfq540","article-title":"The issue of studying the effect of interventions in renal replacement therapy \u2013 to what extent may we be deceived by selection and competing risk?","volume":"25","author":"Jager","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2017.01.007_bib24","first-page":"255","article-title":"Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial","volume":"31","author":"Bhandari","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cjca.2017.01.007_bib25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/CIRCULATIONAHA.116.022536","article-title":"The implications of blood pressure measurement methods on treatment targets for blood pressure","volume":"134","author":"Bakris","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2017.01.007_bib26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.amjhyper.2005.08.016","article-title":"Effect of terminal digit preference on blood pressure measurement and treatment in primary care","volume":"19","author":"Nietert","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cjca.2017.01.007_bib27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/jch.12252","article-title":"Eliminating the human factor in office blood pressure measurement","volume":"16","author":"Myers","year":"2014","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cjca.2017.01.007_bib28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cjca.2011.09.004","article-title":"Automated office blood pressure","volume":"28","author":"Myers","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.01.007_bib29","first-page":"2291","article-title":"A\u00a0randomized trial of intensive versus standard blood pressure control","volume":"374","author":"McCormick","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2017.01.007_bib30","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/HJH.0b013e328356abd3","article-title":"The conventional versus automated measurement of blood pressure in the office (CAMBO) trial: masked hypertension sub-study","volume":"30","author":"Myers","year":"2012","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.cjca.2017.01.007_bib31","doi-asserted-by":"publisher","first-page":"d286","DOI":"10.1136\/bmj.d286","article-title":"Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial","volume":"342","author":"Myers","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2017.01.007_bib32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jash.2013.07.002","article-title":"BpTRUth: do automated blood pressure monitors outperform mercury?","volume":"7","author":"Edwards","year":"2013","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.cjca.2017.01.007_bib33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/fampra\/cmr113","article-title":"Conventional versus automated measurement of blood pressure in the office (CAMBO) trial","volume":"29","author":"Myers","year":"2012","journal-title":"Fam Pract"},{"key":"10.1016\/j.cjca.2017.01.007_bib34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/jhh.2013.38","article-title":"Waiting a few extra minutes before measuring blood pressure has potentially important clinical and research ramifications","volume":"28","author":"Nikolic","year":"2014","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.cjca.2017.01.007_bib35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cjca.2015.08.026","article-title":"Diastolic hypotension in a tertiary care hypertension clinic: have we gone too far?","volume":"32","author":"Mace-Brickman","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.01.007_bib36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cjca.2015.10.013","article-title":"Are we endangering hypertensive patients by overzealous treatment that induces diastolic hypotension? A SPRINT to the answer?","volume":"32","author":"Feldman","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2017.01.007_bib37","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1001\/archinte.159.17.2004","article-title":"The role of diastolic blood pressure when treating isolated systolic hypertension","volume":"159","author":"Somes","year":"1999","journal-title":"Arch Intern Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X17300119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X17300119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:23:48Z","timestamp":1536107028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X17300119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0828282X17300119"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2017.01.007","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision Medicine for Hypertension Management in Chronic Kidney Disease: Relevance of SPRINT for Therapeutic Targets in Nondiabetic Renal Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2017.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}